Edition:
India

People: Sierra Oncology Inc (SRRA.OQ)

SRRA.OQ on NASDAQ Stock Exchange Global Market

0.31USD
11 Oct 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$0.31
Open
$0.33
Day's High
$0.34
Day's Low
$0.31
Volume
138,806
Avg. Vol
139,553
52-wk High
$2.01
52-wk Low
$0.29

Klencke, Barbara 

Dr. Barbara Klencke, M.D. serves as Chief Development Officer of the company., Since June 2015. Previously, Dr. Klencke served as the Senior Vice President, Development at Onyx Pharmaceuticals, a biopharmaceutical company and a subsidiary of Amgen Inc., from January 2011 to June 2015, and as the Group Medical Director in Product Development, Oncology at Genentech, Inc., a biotechnology company, from July 2003 to January 2011. Prior to that, Dr. Klencke served as the Medical Director at Chiron Corporation, a biotechnology company later acquired by Novartis International AG, and as an assistant professor of medicine at the University of California, San Francisco Medical Center. Dr. Klencke holds a B.S. from Indiana University and an M.D. from the University of California, Davis.

Basic Compensation

Total Annual Compensation, USD 1,361,160
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 127,600
Fiscal Year Total, USD 1,488,760

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --